Our Team
Orlance, Inc., headquartered in Seattle, WA, is developing its MACH-1® platform to deliver nucleic acid vaccines and related therapies without cold chain restrictions. Leveraging $13M in NIH SBIR funding, Orlance has developed the MACH-1 platform to intradermally deliver stable, powdered vaccines in a needle-free manner that minimizes dose size, eliminates cold chain requirements, and is poised to increase access and compliance. The company’s lead assets are at Pre-IND stage and poised for Phase 1 readiness in 2023.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_kris-min-2.png)
KRIS AALTO, BS
CEO
25 years of bioengineering,
innovation development,
regulatory and clinical affairs,
product launch, VC and
executive experience.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_deb.png)
DEB FULLER, PHD
CTO
Co-inventor of MACH-1
technology, formerly at
PowderJect, UW Professor, the
lab focuses on NA vaccines for
multiple pathogens.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_ken_tp-min-1.png)
KEN BAGLEY, PHD
Director R&D
15 years in NA
vaccine field, developed genetic
adjuvant platform at Profectus
Biosciences, Inc.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_hannah_frizzell-min-1.png)
HANNAH FRIZZELL, PHD
Program Director, Preclinical Development
Preclinical Development Bioengineer,
Immunology, and nano delivery
system experience.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_lyuda-min-1.png)
LYUDA LEBEDINSKI, BS
Senior Administrative and
Financial Manager
Experienced
biomedical research finance,
federal funding and
management professional.
![](https://orlance.com/wp-content/uploads/2022/10/orlance_atharva.png)
ATHARVA BHALERAO, BS
Research Scientist and Analyst
Preclinical program laboratory
and business development
support.
![RebeccaIDpic (2) RebeccaIDpic (2)](https://orlance.com/wp-content/uploads/elementor/thumbs/RebeccaIDpic-2-1-qeg3uoej444o4x8juuh6ybora8zvfx31w8st14n3tm.png)
BECCA TEODOSIU, BS
Biomedical Engineer
Medical device testing & development, lab support, and vendor management.
![Ariana ID Pic copy (1) Ariana ID Pic copy (1)](https://orlance.com/wp-content/uploads/elementor/thumbs/Ariana-ID-Pic-copy-1-qeg3r7dzv5dj8sa54uft8p8ga04206ar32187bsgt6.png)
Ariana Aalto
Communications and Business Development Intern